Skip to main content
Log in

The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The pharmacodynamic and pharmacokinetic profiles of nifedipine and nisoldipine were compared in a double blind, placebo-controlled study. Nisoldipine, 10 mg significantly reduced systolic blood pressure but nifedipine 20 mg retard did not, although both drugs had significant pharmacodynamic effects as evidenced by increased heart rates. The terminal elimination half-life in plasma was similar for both drugs with a mean of 2 h. The pharmacodynamics of nisoldipine were studied in 8 hypertensives following both acute and chronic administration. Antihypertensive efficacy was demonstrated after acute dosing and was maintained over 4 weeks of twice daily treatment as monotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kazda S, Garthoff B, Meyer H, Schlobmonn K, Stoepel K, Towart R, Vater W, Welringer E (1980) Pharmacology of a new calcium antagonistic compound. Isobutyl methyl 1,4-dihydro-2-6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedecarboxylate (Nisoldipine, Bay K5552). Arzneimittelforsch Drug Res 30 (II), [12]: 2144–2162

    Google Scholar 

  2. Maxwell GM, Crompton S, Rencis V (1982) Effect of nisoldipine upon the general and coronary haemodynamics of the anaesthetized dog. J Cardiovasc Pharmacol 43: 393–397

    Google Scholar 

  3. Warltier DC, Meils CM, Garrett JG, Brooks HL (1981) Blood flow in normal and acutely ischaemic myocardium after verapamil, diltiamem and nisoldipine (Bay K 5552), a new dihydropyridine calcium antagonist. J Pharmacol Exp Ther 218 [1]: 296–302

    Google Scholar 

  4. Hamann SR, McAllister RG (1983) Measurement of Nifedipine in plasma by gas-liquid chromatography and electron capture detection. Clin Chem 29 [1]: 158–160

    Google Scholar 

  5. Millar JA, McLean KA, Sumner DJ, Reid JL (1983) The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man. Eur J Clin Pharmacol 24: 315–321

    Google Scholar 

  6. MacGregor GA, Rotellar C, Markandu ND, Smith SJ, Sagnella AG (1982) Contrasting effects of nifedipine, captopril and propranalol in normotensive and hypertensive subjects. J Cardiovasc Pharmacol 4: S358–362

    Google Scholar 

  7. Littler WA, Watson RDS, Stallard TJ, McLeary RAB (1983) The effect of nifedipine on arterial pressure and reflex cardiac control. Postgrad Med J 59 [Suppl 2]: 109–112

    Google Scholar 

  8. Young MA, Watson RDS, Littler WA (1984) Baroreflex setting and sensitivity after acute and chronic nicardipine therapy. Clin Sci 66: 233–235

    Google Scholar 

  9. Pasanisi F, Reid JL (1983) Plasma nifedipine levels and fall in blood pressure in a 53 year old woman. Eur J Clin Pharmacol 25: 143–144

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pasanisi, F., Meredith, P.A. & Reid, J.L. The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects. Eur J Clin Pharmacol 29, 21–24 (1985). https://doi.org/10.1007/BF00547363

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00547363

Key words

Navigation